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Abstract 16 
Purpose: Maternal high-fat diet affects offspring and can induce metabolic disorders such as non-alcoholic fatty 17 
liver disease (NAFLD). New therapeutic strategies are being investigated as way to prevent or attenuate this 18 
condition. The objective of this study was to evaluate the effect of açaí supplementation in the maternal high-fat 19 
diet on dams and offspring lipid metabolism. Methods: Female Fisher rats were divided in four groups and fed a 20 
control diet (C), a high-fat diet (HF), an açaí supplemented diet (CA) and a high-fat diet supplemented with açaí 21 
(HFA) two weeks before mating, during gestation and lactation. The effects of açaí were evaluated in the male 22 
offspring after birth (P1) and weaning (P21). Results: HFA reduced relative liver weight, fat and cholesterol 23 
liver content in dams and improved liver steatosis as confirmed by histological analyses. HFA increased serum 24 
cholesterol and expression of Srebpf1 and Fasn genes. In offspring, HFA decreased relative liver weight, and 25 
serum cholesterol only in P21. An increase in the Sirt1, Srebpf1 and Fasn genes expression was observed in 26 
P21. Conclusions: These results suggest that açaí supplementation may attenuate NAFLD in dams and protect 27 
offspring from the detrimental effects of lipid excess from a maternal high-fat diet. 28 
Keywords: açaí, Euterpe oleracea Martius, high-fat maternal diet, metabolic programming, non-alcoholic fatty 29 
liver disease 30 
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1. Introduction 45 
Non-alcoholic fatty liver disease (NAFLD) is characterised by accumulation of triglycerides in hepatocytes. 46 
This disease encompasses a spectrum of conditions ranging from simple hepatic steatosis to non-alcoholic 47 
steatohepatitis (NASH) characterised by the presence of inflammation, which can progress to cirrhosis or 48 
hepatic carcinoma [1]. The prevalence of NAFLD in children and adolescents has evidenced the role of maternal 49 
nutrition during critical periods of fetal development [2]. Metabolic programing is a process by which maternal 50 
lifestyle (including diet) promote modifications in the uterus environment or milk composition that can trigger 51 
several changes in the sequence of events, in the gestational or lactation periods, leading to metabolic disorders 52 
in the offspring [3]. The molecular mechanisms and pathways involved are not well understood but some studies 53 
have pointed epigenetics changes as having a pivot role in the process [4]. This is a current and extremely 54 
relevant concept due to the pandemic of metabolic diseases, such as diabetes, obesity and systemic arterial 55 
hypertension [5] that might be partially explained by metabolic programming. High-fat maternal diet has been 56 
widely used in the literature to induce NAFLD in experimental animal models and the consumption of such diet 57 
reflects the current world scenario in which excessive lipid intake may contribute to rise of liver diseases in the 58 
population [6,7]. Over the last decade, considerable progress has been made in understanding how the excess of 59 
lipid intake via maternal diet alters metabolic pathways in the uterus, predisposing the fetus to accumulation of 60 
fat in the liver, and consequently the development of NAFLD in adult life [8]. 61 
Sirtuins, a family of proteins dependent on intracellular levels of NAD+, stood out because of their important 62 
role in energy metabolism [9]. Sirtuin 1 (SIRT1) has been extensively studied due to its involvement in several 63 
metabolic processes: it deacetylates the sterol regulatory element-binding protein (SREBPs) promoting 64 
inhibition of its activity [10]. SREBPs are transcription factors and three different isoforms, SREBP-1a, 65 
SREBP-1c and SREBP-2, are present in mammalian cells. SREBPs directly activate the expression of more than 66 
thirty genes related to the synthesis and uptake of cholesterol, fatty acids, triglycerides and phospholipids, in 67 
addition to increase the expression of genes involved in the generation of NADPH, a necessary cofactor used in 68 
anabolic reactions such as lipid metabolism [11]. In general, SREBP-1 regulates transcription of lipogenic 69 
genes, ranging from genes involved in fatty acid biosynthesis to gene regulation of the enzyme fatty acid 70 
synthase (FASN). Studies evaluating the effect of maternal diet have shown that the excess of lipids can reduce 71 
the expression and activity of SIRT1 in the liver of mothers and offspring, causing alterations in liver 72 
metabolism and promoting fat accumulation [12,13]. 73 
Under normal physiological conditions, fat accumulates in adipose tissue and not in the liver; however, lipid 74 
accumulation in the liver can occur when there are alterations between mobilisation and lipid oxidation. Studies 75 
have shown that excess of fatty acids may promote mitochondrial dysfunction and reduce oxidative capacity of 76 
mitochondria in mothers and their offspring [14]. The lipid influx, in addition to compromised oxidative 77 
capacity of the mitochondria, can result in accumulation of partially oxidised lipid products and generation of 78 
additional reactive oxygen species (ROS), which can overwhelm cell defenses leading to oxidative stress [15]. 79 
In this sense, mitochondrial uncoupling protein 2 (UCP2) has emerged as a potential regulator of hepatic 80 
steatosis. UCP2 allows the transfer of anions from the inner mitochondrial membrane to the cytosol and the 81 
return transfer of protons from the outer to the inner membrane [16]. It is, therefore, possible that UCP2 is 82 
capable of attenuating hepatic steatosis through the control of ROS production [17]. 83 
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Together with studies that seek to better understand changes that occur in the womb and precede development of 84 
metabolic disorders, the search for new therapeutic targets and the introduction of foods with a potential 85 
beneficial effect on metabolism have emerged in the scientific field. The most common compound studied is 86 
resveratrol, a polyphenol naturally found in purple grapes and widely accepted as chemoprotective agent [18]. In 87 
models of hepatic steatosis induced by high-fat maternal diet, administration of resveratrol was shown to 88 
efficiently reduce plasma and hepatic storage of triglycerides, both studies through SIRT1 upregulation in 89 
offspring [19,20,10,21]. Moreover, other polyphenols such as flavonoids, flavonols, anthocyanidins, flavonones, 90 
and isoflavones have been studied as potential agents for the prevention and treatment of NAFLD [21]. 91 
Therefore, the activation of SIRT1 by polyphenols would be beneficial for the prevention and treatment of 92 
NAFLD. 93 
Açaí (Euterpe oleracea Martius), an Amazon fruit, with a high content of phenolic compounds of the class of 94 
anthocyanins, mainly cyanidin-3-rutinoside, cyanidin-3-glycoside, cyanidin-3-sambubioside, peonidin-3-95 
glycoside and peonidin-3-rutinoside [22] has been the subject of research seeking to evaluate its potential 96 
beneficial effect on health. Recent work evaluating the effect of açaí on NAFLD pathology, demonstrated a 97 
hepatoprotective action of this fruit by modulating the expression of genes involved in adiponectin signalling, 98 
lipogenesis and oxidation of fatty acids [23,24]. However, little is known about the effect of açaí on the 99 
molecular mechanisms involving hepatic and lipid metabolism in NAFLD induced by high-fat maternal diet and 100 
its effect on offspring. Our hypothesis is that, due to its high content of polyphenols, açaí supplementation in 101 
dams’ diet two weeks before mating and during gestation and lactation, protects them and their offspring against 102 
NAFLD induced by high-fat diet. The aim of this study was, therefore, to evaluate pathways involved in the 103 
development of NAFLD in rats, which may be modified by supplementing a high-fat diet with 2% of açaí pulp 104 
during gestation and lactation. Moreover, the effect of such intervention was studied in postnatal and post-105 
weaning offspring.  106 
2. Materials and Methods 107 
2.1 Açaí Pulp  108 
Pasteurised frozen açaí pulp without colorants or preservatives was obtained in a single lot (07/2016) from 109 
Icefruit Comércio de Alimentos Ltda (Tatui, São Paulo, Brazil). Chemical analysis of the pulp showed moisture 110 
content of 90%, 3.9 g lipids, 2.3 g total carbohydrate, 0.9 g protein, 2.3 g insoluble fiber and 0.4 g soluble fiber 111 
per 100g of pulp. 112 
Polyphenol content of açaí pulp was determined by using Folin-Ciocalteu reagent as described previously [25]. 113 
A standard curve was constructed using different concentrations of gallic acid for quantifying total polyphenols 114 
and values were expressed in mg of gallic acid equivalent (GAE) in 100g of açaí pulp. The açaí pulp used in this 115 
study presented 549.5 mg GAE/100g. The content of anthocyanins was also measured as reported by Giust and 116 
Wrolstad (2001) [26]. The assay consists of the pH differential method and the values were expressed as 117 
cyanidin-3-glucoside equivalents, mg/L of pulp. The total anthocyanin of açaí pulp was 6.5 mg/L.  118 
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2.2 Animals and diets 119 
All procedures used in this study were approved by the Ethics Committee in Animal Research of the Federal 120 
University of Ouro Preto (Protocol No. 2015/15). Thirty-two female Fischer rats (90 days of age) were obtained 121 
from the Laboratory of Experimental Nutrition at the School of Nutrition of the Federal University of Ouro 122 
Preto (Minas Gerais, Brazil). Animals were divided in four groups receiving different diets: control diet (C), 123 
high-fat diet (HF, 60% of total calories as fat, been 53% saturated fat, 6% soybean oil and 1% cholesterol), 124 
control diet supplemented with açaí pulp (CA, control diet plus 2% of açaí pulp) or high-fat diet supplemented 125 
with 2% of açaí pulp (HFA). Control diet and high-fat diet were based on the AIN-93G diet, with some 126 
modifications according to previous studies [23,27-29]. All animals were maintained in a standard environment, 127 
23°C ± 2°C, 55% humidity and 12-h light/darkness cycle, with food and water provided ad libitum. Initially, 128 
animals were fed with the respective experimental diets for two weeks. After one week, we evaluated the food 129 
intake. After two weeks in the experimental diets, the mating was performed with a male rat together with two 130 
females for one week. After the mating period, females were separated and housed in individual cages to allow 131 
the natural progression of gestation while continuing to receive the allocated diet during gestation and lactation. 132 
The dams body weight was measured in the first week, pre-mating week, and in the day of euthanise. At birth, 133 
some of the male pups (n=7) were anesthetised under isoflurane and euthanised by decapitation (postpartum 134 
offspring, P1), whereas the rest of the pups were kept, six per dam, in order to guarantee homogeneous growth 135 
of the litters. At weaning, the dams and the remaining offspring male (P21) were euthanised as above. Male 136 
pups were chosen as to reflect the higher incidence of NAFLD in male population [30] and seven male pups of 137 
each group were randomly selected for all the analysis. 138 
2.3 Collection of blood and tissue samples 139 
At the end of the experimental period, dams and P21 (n=7 per group) were anesthetised under isoflurane, after 140 
12-hours fasting, and sacrificed by total blood collection from the brachial plexus. Blood samples were collected 141 
and centrifuged at 3000 g for 15 min at room temperature. Serum was then removed and stored at - 80°C for 142 
further analyses. Livers from dams, P1 and P21 were collected, washed with cold saline solution and weighed. 143 
The small hepatic lobe was submerged in liquid nitrogen and immediately stored at -80°C for gene and protein 144 
expression analyses. 145 
2.4 Blood chemistry 146 
Enzymes activities for aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured in 147 
serum samples using a fixed time kinetic reaction following manufactures’ instructions (Labtest, Lagoa Santa, 148 
Brazil). The levels of serum triglycerides (TG) and total cholesterol (TC) were determined using a colorimetric 149 
assay acquired from Labtest (Lagoa Santa, Brazil) following manufacturer’s instructions. 150 
2.5 Lipid liver content 151 
Hepatic lipids were extracted from liver tissue using a chloroform/MeOH solution (2:1, v/v), as described by 152 
Folch et al. (1957) [31]. The content of total lipids in the liver was quantified gravimetrically by evaporation of 153 
the solvents and dissolution of the dried lipids in 500μl of isopropanol. Concentrations of TG and TC were 154 
determined colorimetrically using TG and TC assay kits (Labtest, Lagoa Santa, MG, Brazil). 155 
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2.6 Histological examination 156 
Liver smallest lobe was cut and fixed in 4% formalin buffered solution. After fixation, the tissues were cleared 157 
and processed in decreasing concentrations of alcohol and sealed in paraffin. Through a semi-automatic 158 
microtome, the paraffin sections were laminated (4 μm), stained with hematoxylin and eosin (H&E) and 159 
photographed at 40x magnification (Leica Application Suite, Germany). Liver histology was examined using 15 160 
images obtained at random from the tissue and classified for the degree of macro vesicular steatosis. The degree 161 
of hepatic steatosis was assessed according to scores defined in previous studies and based on the percentage of 162 
hepatocytes that present accumulation of fat, being absent <5%; mild between 6% and 33%; moderated between 163 
34% and 66%; marked > 66% of affected hepatocytes [32].  164 
2.7 Quantitative reverse transcription polymerase chain reaction analysis 165 
Total RNA extraction was performed from 10-20mg of frozen liver tissue using TRI Reagent® Solution 166 
(Invitrogen, UK) following the manufacturer’s instructions. RNA purification was checked by the ratio 167 
A260/A280, utilizing a UV/VIS spectrophotometer (Thermo Spectronic, Helios γ). One hundred ng of RNA was 168 
transcribed to cDNA by RT-PCR using Super Script III Reverse Transcriptase (Invitrogen, UK) and random 169 
hexamers as primers (Promega, UK). The cDNA product was used as template in the quantitative real time PCR 170 
(qPCR) reaction performed with SYBR Green PCR Master Mix kit (Primer design, UK), as recommended by 171 
the manufacturer. Reactions were done in duplicate and each reaction had a negative control with water added 172 
instead of template. The sequences of oligonucleotide primers for qPCR are noted in table 1. mRNA levels were 173 
analysed using comparative Ct method and target gene expression was related to the expression of the house 174 
keeping gene, β2 microglobulin. 175 
2.8 Western blotting 176 
Frozen liver samples were homogenized in Cell Lysis buffer (Cell Signaling Technology, Inc. Danvers, MA, 177 
USA) containing 40 mM Tris-HCl (pH 7.5), 300 mM NaCl, 2 mM Na2EDTA, 2 mM EGTA, 2% Triton, 5 mM 178 
sodium pyrophosphate, 2 mM β-glycerophospate, 2 mM Na3VO4, 2 µg/ml leupeptin, a cocktail of protease 179 
inhibitors (Sigma, St Louis, MO) and 1 mM PMSF following the manufacturer’s instructions. Liver 180 
homogenates were centrifuged at 13000 g for 15 min at 4°C and supernatants were aliquoted and stored at -181 
80°C. Protein concentration was measured by DC™ protein assay (Bio-Rad, UK) following kit guidelines. 182 
Thirty µg of total protein for pulled samples from each experimental group were loaded per lane (pulled samples 183 
were run in duplicate per gel), subjected to 9% SDS-PAGE, and transferred to polyvinylidene fluoride (PDVF) 184 
membranes (GE Healthcare, USA) by wet transfer at 100 V for 1h using a Mini Trans-Blot cell system (Bio-Rad 185 
Laboratories, Hercules, CA). Membranes were blocked using 4% non-fat dry powered milk dissolved in Tris-186 
buffered saline tween-20 (TBST) for 1h at room temperature. The primary antibodies for SIRT1 (ab110304), 187 
SREBP1 (ab28481) and beta actin (ab8227) (all antibodies obtained from Abcam, Cambridge, UK) were used 188 
according to the manufacturer recommended dilutions (1:2000 for SIRT1 and SREBP, 1:10000 for Actin) and 189 
were incubated overnight at 4°C. The membranes were then washed three times for 5 min with TBST, before 190 
incubation for 1h at room temperature with secondary peroxidase conjugated goat anti-rabbit (ab6721, Abcam, 191 
Cambridge, UK) or goat anti-mouse (ab205719, Abcam, Cambridge, UK) diluted at 1:5000 in 4% non-fat dry 192 
milk–TBST. Membranes were washed as before, and the bound antibodies were visualized by enhanced 193 
chemiluminescence (ECL) SuperSignal® (ThermoScientific, USA) using a peqLab Fusion FX7 system 194 
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(VilberLourmat). Beta actin levels were used as control and levels of SIRT1 and SREBP1 were related to beta 195 
actin levels. Image J software was used to calculate band intensity.  196 
2.9 Statistical analysis 197 
Statistical analysis was performed using GraphPad Prism 6 for Windows (GraphPad Software, San Diego, CA). 198 
All data were tested for normality using the Kolmogorov-Smirnov test. Parametric data from the four groups 199 
were analysed by one-way ANOVA followed by Tukey test to detect differences between the groups and 200 
expressed as mean ± standard deviation (SD). Non-parametric data (western blotting) or semi-quantitative 201 
analyses (histology data) were compared using Wilcoxon and Kruskal-Wallis respectively. The data were 202 
presented as median and range (minimum and maximum values). Data from two groups were compared by 203 
Student t-test unpaired one tail. Results were considered statistically significant for p values < 0.05. 204 
3. Results 205 
3.1 Dams 206 
3.1.1 Effect of dietary intervention on body weight, tissue weight and food intake 207 
The different experimental groups did not present significant changes in body weight in the initial and pre-208 
gestational period. However, at the end of the study, rats receiving HFA had significantly greater body weight 209 
(19%, p=0.0128) than the C group (Table 2). Liver weight was also measured at the end of experiment (Table 210 
2): HF group showed a significant increase in the total organ size compared to C (46%, p=0.0007) and CA 211 
(73%, p<0.0001) groups, while HFA presented an increase in relation to CA group (42%, p=0.0088). However, 212 
when evaluating the relative liver weight, a statistically significant reduction (25%, p=0.0277) was observed in 213 
the HFA group in comparison to HF. HF group presented an increase in relative liver weight in relation to C 214 
(34%, p=0.0331) and CA (76, p=0.0002) groups. Regarding to food intake, the supplementation with 2% of açaí 215 
pulp did not affect the caloric intake of the dams (Table 2). 216 
3.1.2 Effect of dietary intervention on serum lipid profile and hepatic function 217 
Dams fed a HFA presented a significant increase in total cholesterol when compared to C (86%, p=0.0049), HF 218 
(53%, p=0.0492) and CA (147%, p=0.0004) groups, whereas no change was observed in serum triglyceride 219 
levels (Table 2). 220 
The activities of AST and ALT were determined in serum as biomarkers of the extent of hepatic damage (Table 221 
2). HF and HFA groups showed a significant increase (48%, p=0.008 and 51%, p=0.0045, respectively) in AST 222 
when compared to the C group, whereas ALT activity was significantly increased in the HF (168%, p=0.0001 223 
versus C group; 152%, p=0.0002 versus CA group) and HFA groups (161%, p=0.0002 versus group C; 146%, 224 
p=0.0003 versus CA group). 225 
3.1.3 Effect of dietary intervention on liver lipid content 226 
The content of total fat, cholesterol and triglyceride in the liver was evaluated to assess the extent of NAFLD, 227 
the results are presented in table 2. A significant increase in total fat content was observed in the HF group in 228 
relation to C (117%, p=0.0006), CA (278%, p<0.0001) and HFA (82%, p=0.004). Interestingly, CA group 229 
showed a decrease in fat liver content even if it did not reach statistical difference compared to C group, 230 
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whereas HFA did not induce an increase in fat liver content as the HF diet did. Hepatic cholesterol levels were 231 
higher in the HF (654%, p<0.0001 versus C; 742%, p<0.0001 versus CA) and HFA (358%, p<0.0001 versus C; 232 
412%, p<0.0001 versus CA), but the HFA group presented lower values in relation to the HF group (36%, 233 
p=0.0001). Liver triglyceride content in the HF group was also significantly higher than that observed in the CA 234 
group (61%, p=0.0268). 235 
3.1.4 Effect of dietary intervention on liver steatosis grade 236 
To evaluate the effect of the different diets on accumulation of lipids and degree of steatosis in the liver, 237 
microscopic analysis was performed. Histological analysis revealed that the HF group had a higher grade of 238 
steatosis (moderate and marked), whereas the HFA group had an attenuation of steatosis when compared with 239 
HF (Figure 1a). Scoring of the degree of steatosis confirmed the presence of moderate to marked steatosis in the 240 
liver of dams fed a HF diet which was reduced to mild-moderate (p<0.01) by açaí supplementation to HF diet 241 
(Figure 1b). 242 
3.1.5 Effect of dietary intervention on gene expression involved in lipid metabolism  243 
In order to determine the potential metabolic pathways by which açaí could improve hepatic fat accumulation, 244 
the expression of genes involved in lipid metabolism was assessed (Figure 2). Sirt1 mRNA abundance was 245 
higher in the HFA group compared to HF group, but no statistically significant differences were found. 246 
Surprisingly, the HFA group showed an increase in the relative expression of Srebf1 (3-fold change, p=0.0092) 247 
and Fasn (4-fold change, p=0.0241) genes when compared to the HF group.  248 
3.1.6 Effect of dietary intervention on protein levels 249 
Western blot analysis did not show significant differences in SIRT1 protein levels (Figure 3a) even if a trend for 250 
increased levels in the HFA group could be observed. Although gene expression showed an increase in Srebpf1 251 
in the liver of the dams fed a HFA diet, protein level did not show statistical difference compared to levels in the 252 
HF group (Figure 3b). 253 
3.2 Offspring 254 
3.2.1 Effect of dietary intervention on body and tissue weight  255 
The effect of a high-fat diet supplemented or not with açaí during gestation on offspring was investigated in 256 
pups euthanised 1 day after birth (P1). Body weight did not change between groups (Table 3), whereas, when 257 
considering the absolute and relative weight of the liver, the pups HFA-P1 showed a decrease of 27% in organ 258 
size and 33% in relative weight (p=0.0088 and p=0.0126, respectively; Table 3) compared to HF-P1 group. 259 
Similarly, the effect of the different diets during gestation and lactation was assessed in pups culled at the end of 260 
the lactation period (P21). An increase in the body weight of pups from HF-P21 (40%, p=0.0067 versus CA-261 
P21) and HFA-P21 (25%, p=0.0343 versus C-P21; 60%, p<0.0001 versus CA-P21) (data shown in Table 3) was 262 
observed. The absolute liver weights were also measured at the end of the experiment and pup livers showed an 263 
increase from HF-P21 (47%, p=0.0002 versus C-P21; 59%, p<0.0001 versus CA-P21) and HFA-P21 (40%, 264 
p<=0.0015 versus C-P21; 51%, p=0.0002 versus CA-P21). Açaí supplementation reduced the relative weight of 265 
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the liver by 17% (p=0.0263, HFA-P21 versus HF-P21), whereas feeding a HF diet induced an increase of 35% 266 
in relative liver weight (Table 3, p=0.0006, HF-P21 versus C-P21).  267 
3.2.2 Effect of dietary intervention on lipid profile and hepatic function 268 
The effect of the different maternal diets on lipid metabolism was evaluated by measuring serum levels of 269 
cholesterol and triglycerides (Table 4). Pups HF-P21 presented, after gestation and lactation, a significant 270 
increase in serum cholesterol in relation to C-P21 (58%, p=0.0004) and CA-P21 (48%, p=0.0018) groups, 271 
whereas HFA-P21 group induced a significant decrease in cholesterol levels (57%, p<0.0001) when compared 272 
to HF-P21 group. No differences were observed for triglyceride concentrations among the different diets. 273 
The activities of AST and ALT enzymes were also determined in the pups’ serum after weaning (Table 4) and 274 
no difference was found between groups.  275 
3.2.3 Effect of dietary intervention on liver lipid content 276 
To assess the effect of maternal diet on promoting early changes in liver dynamics, lipid metabolism, total 277 
content of fat, cholesterol and triglyceride levels were evaluated in the liver of offspring after the lactation 278 
period (Table 4). No significant differences were found in liver fat values between groups. HF-21 and HFA-P21, 279 
during gestation and lactation, induced an increase in total cholesterol concentration in the liver when compared 280 
to C-P21 (144%, p<0.0001 versus HF-P21; 134%, p<0.0001 versus HFA-P21) and CA-P21 (134%, p<0.0001 281 
versus HF-P21; 124%, p<0.0001 versus HFA-P21). Regarding to the triglycerides liver content, açaí supplement 282 
in control diet was able to prevent the increase in the triglycerides after the lactation period (Table 4). CA-P21 283 
group presented reduction in liver triglycerides when compared to HF-P21 and HFA-P21 groups (87%, 284 
p=0.0077 and 90%, p=0.0055, respectively). 285 
3.2.4 Effect of dietary intervention on liver steatosis grade 286 
Through histology of P21 livers (Figure 4a), it was possible to observe that HF-P21 had more lipid droplets 287 
compared to any other group. In relation to degree of steatosis, HF-P21 group presented a steatosis degree (mild 288 
to moderate, Figure 4b) more pronounced than in CA-P21 and HFA-P21 groups (absent to mild). HFA-P21 289 
group presented a lower degree of steatosis, endorsing the protective effect of açaí in relation to accumulation of 290 
hepatic lipids. 291 
3.2.5 Effect of dietary intervention on expression of genes involved in lipid metabolism 292 
In order to identify some of the potential molecular pathways involved in lipid metabolism and affected by a 293 
diet supplemented with açaí during the gestation and lactation process, gene expression was assessed in P1 and 294 
P21 offspring, respectively.  No statistically significant differences were observed in the gene expression of P1  295 
(Figure 5a). 296 
Similarly, the expression of lipid metabolism genes was assessed in the liver from pups after the lactation period 297 
(Figure 5b). Expression of Sirt1 (0.5-fold change, p=0.0168), Srebf1 (4-fold change, p=0.0274) and Fasn (5-fold 298 
times, p=0.004) was increased in the HFA-P21 liver when compared to HF-P21. No significant differences were 299 
found in Ucp2 gene expression (Figure 5b). 300 
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3.2.6 Effect of dietary intervention on protein expression  301 
SIRT1 and SREBP1 protein expression was analysed in offspring P1 (Figure 6a and 6b) and P21 (Figure 6c and 302 
6d) from different maternal diets. No significant differences were observed between the groups. In the same way 303 
as it was seen in the dams, the overexpression of Srebf1 showed no increase in the expression of the respective 304 
proteins. 305 
4. Discussion 306 
In the present study, we evaluated the effects of açaí supplementation in combination with a maternal high-fat 307 
diet on lipid and liver metabolism of dams and offspring postnatally or post lactation. Our results revealed that, 308 
in dams, the high-fat diet increased absolute liver weight, serum ALT and AST enzyme activity, hepatic total fat 309 
content, cholesterol and triglycerides: changes that are consistent with the development of NAFLD. The 310 
addition of açaí in the maternal high-fat diet reduced some of NAFLD characteristics, including relative liver 311 
weight and hepatic fat content, in agreement with previous studies conducted with hyperlipidemic and 312 
hypercholesterolemic diet in rats and mice which showed açaí to improve hepatic steatosis and reduce the 313 
deleterious effects of lipid excess [17,16]. Although these studies were not performed with rodents during 314 
gestation or lactation, the results of our study suggest an important role of açaí also in specific physiological 315 
states. Regarding to the offspring, açaí consumption during gestation and lactation was able to reduced serum 316 
cholesterol and degree of steatosis in P21, suggesting this fruit can to modify offspring’s lipid metabolism, 317 
conferring protective effect to the development of hepatic steatosis.  318 
Maternal high-fat diet affected the health of offspring by promoting changes that may trigger the development 319 
of metabolic diseases later in life such as diabetes, insulin resistance, obesity, cardiovascular disease and asthma 320 
[33]. Studies have described that excess of maternal nutrition during gestation, in combination with a high-fat 321 
postnatal diet, is capable of promoting phenotypic alterations, like increased body weight, hyperinsulinemia, 322 
hyperglycemia, hypertryglyceridemia and hypercholesterolemia [34,35]. In contrast, the introduction of foods 323 
such as green tea and guarana can improve serum levels of ALT, cholesterol, triglycerides, HDL and glucose in 324 
offspring [36,37]. In our study, the addition of açaí to the maternal high-fat diet reduced serum levels of total 325 
cholesterol in offspring P21 relative to the HF-P21 group. Differently from what was found in the dams, açaí 326 
was not able to change the weight and/or fat content in the liver of HF-P21 group. It is possible that the degree 327 
of damage caused by the HF diet in the offspring is smaller than in dams and, therefore, the supplementation of 328 
açaí in the maternal diet was more effective in mitigating effects at plasma level. In fact, a recent study 329 
evaluating the introduction of jussara (a kind of açaí) into a maternal diet enriched with hydrogenated vegetable 330 
fat, reported a reduction in plasma levels of glucose, total cholesterol and triglycerides in offspring receiving 331 
jussara fruit supplementation in a maternal high-fat diet [38]. Another study evaluating the administration of 332 
different types of fat (vegetable oil, lard, hydrogenated vegetable oil and fish oil) during gestation and lactation 333 
reported that the administration of omega-3 was able to reduce HDL and serum total cholesterol in dams, 334 
whereas in the offspring there was a reduction in the serum and hepatic levels of triglycerides, as well as a 335 
decrease in total cholesterol and free fatty acids [39]. 336 
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In order to better understand our results, we evaluated if modulation of the lipid biosynthesis or fatty acids β-337 
oxidation was responsible for improvement of NAFLD in dams and possibly in offspring after lactation and 338 
gestation. SIRT1 is an important regulator of lipid metabolism in the liver [40]. Fat-rich diets have been shown 339 
to reduce the expression of Sirt1 making the liver more susceptible to fat accumulation [41]. This has also been 340 
observed in the liver of animals from a maternal high-fat diet, suggesting that the metabolic programming of 341 
NAFLD may be involved in the downregulation of Sirt1 [42,43]. In this regard, the use of compounds capable 342 
of activating SIRT1 has emerged as an excellent alternative to attenuate fat accumulation in hepatocytes [44]. In 343 
the present work, a trend for increased levels of Sirt1 mRNA expression was observed in dams and P1 group 344 
after the addition of açaí to the HF maternal diet, and reached statistical difference in the P21 HFA group (0.5-345 
fold change). However, no changes in protein levels were observed. Açaí is a food that presents high 346 
concentration of phenolic compounds, mainly of the class of anthocyanins [22]. We believed that it might be 347 
possible to regulate these compounds in the activation of SIRT1 and subsequently in the improvement of 348 
NAFLD. It is worth noting that we did not use in this study isolated antioxidant compounds, but the açaí pulp as 349 
a food that presents in its composition other dietary compounds that can positively affect the lipid metabolism in 350 
the liver through the regulation of other ways. Pathways associated to lipid metabolism are dependent on the 351 
expression and activation of SREBP1 and key enzymes of lipid biosynthesis such as FAS and dietary 352 
components like PUFA and MUFA fatty acids have been shown to regulate the expression of Srebf1 and 353 
lipogenic genes, reducing the accumulation of hepatic fat [45]. Therefore, the high proportion of unsaturated 354 
fatty acids (>70%) present in the lipid fraction of açaí, besides the presence of phenolic compounds, may affect 355 
positively lipid metabolism in the liver [22]. In this study, dams and HFA-P21 groups, showed an increase in the 356 
Srebf1 and Fasn mRNA compared to the HF group. Although the results show higher levels of Srebf1 mRNA in 357 
the HFA group, there appear to be post-translational regulation, since no changes in SREBP1 protein expression 358 
was observed in dams and P21. Such results reflect the complexity of lipid metabolism regulation by dietary 359 
components. As an example, a study carried out in mice to investigate the effect of different fruits, including 360 
açaí, on obesity and metabolic disorders, showed that the groups of animals receiving a high-fat diet 361 
supplemented with açaí presented higher glucose and fasting insulin levels compared to groups that received 362 
other fruits [46]. In addition, açaí-fed animals showed increased regulation of genes associated to lipid and 363 
cholesterol biosynthesis, such as Cidea, Cidec and Anxa2 [47]. In general, the results showed an exacerbation of 364 
fatty liver disease by açaí. However, it is important to note that the amount of açaí used in that study was 20%, 365 
different from our study that evaluated the effect of supplementation with 2% açaí pulp. Moreover, in other 366 
study, açaí has been shown to have beneficial effects on cholesterol concentration by increasing its elimination 367 
by bile via modulation of gene expression for Abcg5 and Abcg8 carriers, as well as up-regulation of the Srebf2 368 
mRNA [48]. This intriguing observation raises another question about how açaí is able to improve the liver fat 369 
accumulation. The current study does not provide data to directly answer this question, but other pathways can 370 
be altered. It is possible that the presence of fibers in the açaí can increase the excretion of cholesterol and 371 
consequently influence on the lipid metabolism, as observed in previous studies with adults rats [48]. In 372 
addition, modifications in oxidative metabolism may contribute to the improvement of hepatic lipid 373 
accumulation found in this study. Pereira et al., showed that hyperlipidaemic rats treated with açaí pulp was able 374 
to prevent the oxidation of LDL and to increase the expression of PON1 and ApoA-I, important molecules 375 
related oxidative stress and lipid metabolism [24,49,50]. However, this study it was not conducted in a specific 376 
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state such as gestation and lactation. Other hand, unsaturated fatty acids may provide an increase in the 377 
expression and activity of the LDL receptors in the liver [51]. PUFAs found in high amounts in açaí can act as 378 
potent activators of the peroxisome proliferator-activated receptor family (PPARs) that regulate other genes 379 
involved in lipid metabolism.   380 
In order to verify the ability of açaí to increase lipid oxidation and thus improve lipid accumulation, levels of 381 
Ucp2 mRNA were assessed. No differences were found in the liver of dams and P1.  Regarding the offspring 382 
P21, although the Ucp2 gene expression was 166% higher, no statistically significant difference was observed.. 383 
In view of the role of UCP2 in reducing ROS and promoting efficient mitochondrial oxidation, an increase in 384 
Ucp2 expression could suggest an increase in the beta oxidation of fatty acids in P21. In fact, a study evaluating 385 
the effect of açaí aqueous extract on hepatic steatosis in adults mice, showed an increase in carnitine-palmitoyl 386 
transferase (CPT-I), a key enzyme in the entry of fatty acids to β-oxidation [23]. In addition, uncoupling 387 
proteins also carry the transport of fatty acid anions and lipoperoxide anions through the inner mitochondrial 388 
membrane [17]. This mechanism can be interpreted as a way to relieve the matrix of lipids excess. Therefore, 389 
UCP2 could also act in the protection of the liver against hepatocellular lipotoxicity [52]. One hypothesis is that 390 
the presence of bioactive compounds in açaí confers a beneficial effect in the fat liver accumulation through the 391 
reduction of oxidative stress, since açaí is rich in polyphenols and anthocyanins, and regulation of the 392 
production of ROS alleviates accumulation of fat droplets in the liver, as observed in our study with an 393 
improvement in fat liver content and grade of steatosis. A study by Chen et al. (2018), using sugar kefir, 394 
demonstrated a reduction in lipid peroxidation levels and increased the activity of superoxide dismutase (SOD) 395 
and catalase (CAT) enzymes [53]. The mechanisms involve the activation of NRF2, an important regulator of 396 
oxidative stress and the production of ROS [54,55]. However, future studies involving redox metabolism need 397 
to be performed. 398 
Açaí has also a high fiber content (30%), of which more than 20% is of the soluble type [22]. Fibers are known 399 
to promote a lower intestinal absorption of cholesterol from the diet and, consequently, increase the release of 400 
this sterol through chylomicrons [56]. Dietary fiber has been shown to be responsible for the increased biliary 401 
excretion in rats, thereby reducing serum cholesterol and blocking the enterohepatic circulation preventing reuse 402 
of bile acids by the liver [57]. In addition, dietary fibers seem to act indirectly in the expression of genes 403 
involved in the metabolism of hepatic cholesterol through secondary signals generated by metabolites produced 404 
in the intestine during fermentation [58], however this mechanism has not yet been fully elucidated. It is 405 
possible that the antioxidant effect of açaí can act directly on the pathways of oxidative stress, neutralizing free 406 
radicals and softening the damage caused by excess of lipids. It is important to remember that the açaí used in 407 
this study is a whole fruit. It is difficult to define which compound is responsible for the improvements observed 408 
in dams and offspring: a synergism between the different macro and micronutrients, as well as phytochemicals 409 
present in açaí may be responsible. 410 
Currently, due to the increase in NAFLD in the paediatric population and the high prevalence of maternal 411 
obesity, several studies have emerged to understand how the maternal high-fat diet is able to “programming” the 412 
fetal liver and predispose the organism to early metabolic disorders. Nevertheless, studies that report the effects 413 
of combining a high-fat diet and foods or bioactive compounds into the development of NAFLD through 414 
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molecular pathways are still limited. Epigenetic studies becomes important in metabolic programming models, 415 
since post-translation modifications in mRNA as repression or degradation may be occurring via microRNAs 416 
[59]. In addition, the increase or reduction of methylation in gene promoting regions is also related to regulation 417 
in gene expression [60]. Recent work had reported alterations in epigenetic mechanisms and possible regulation 418 
through bioactive compounds [61]. Furthermore, it is known that NAFLD is a complex disease that involves, 419 
besides lipid metabolism, changes in the insulin cascade, which were not evaluated in this study. The 420 
acetylated/deacetylated fractions of the SREBP1 transcription factor were not evaluated, which could promote a 421 
more accurate response in relation to the increase in Sirt1 expression and its effect on SREBP1. We have 422 
observed an improvement in the liver lipids of the HFA dams. We do not believe that this effect was in 423 
detriment of the offspring once the total and relative liver weights (HFA-P1 and HFA-P21), as well as the total 424 
serum cholesterol were reduced in HFA-P21. High-fat diet promotes changes in lipid metabolism involving the 425 
crosstalk between liver and adipose tissue and this could explain the alterations in the dams lipid liver 426 
metabolism; however, one of the limitations of the study is the lack of data on the adipose tissue of dams and 427 
offspring. Although modifications in adipose tissue have not been evaluated, our work contains valuable data on 428 
açaí supplementation during specific physiological periods, such as gestation and lactation. Future studies could 429 
be conducted to evaluate the effect of açaí on lipid metabolism of adipose tissue. 430 
In summary, the introduction of açaí to the maternal high-fat diet was able to exert a beneficial effect on the 431 
lipid metabolism of the dams, reducing the accumulation of hepatic fat, liver levels of total cholesterol and 432 
degree of steatosis. Açaí effects were observed in the offspring at serum level, suggesting that the hepatic 433 
damage caused by the high-fat maternal diet in offspring could be delayed with the introduction of foods rich in 434 
bioactive compounds and, therefore, have beneficial effects on health. More studies are needed to better 435 
understand the mechanisms involved in order to justify the effects of açaí supplementation during gestation and 436 
lactation. 437 
14 
 
Conflict of Interest 438 
The authors declare that they have no conflict of interest. 439 
440 
15 
 
References 441 
1. Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7 (4):195-203. 442 
doi:10.1038/nrgastro.2010.21 443 
2. Stewart MS, Heerwagen MJ, Friedman JE (2013) Developmental programming of pediatric nonalcoholic 444 
fatty liver disease: redefining the"first hit". Clin Obstet Gynecol 56 (3):577-590. 445 
doi:10.1097/GRF.0b013e3182a09760 446 
3. Li M, Sloboda DM, Vickers MH (2011) Maternal obesity and developmental programming of metabolic 447 
disorders in offspring: evidence from animal models. Exp Diabetes Res 2011:592408. doi:10.1155/2011/592408 448 
4. Hochberg Z, Feil R, Constancia M, Fraga M, Junien C, Carel JC, Boileau P, Le Bouc Y, Deal CL, Lillycrop 449 
K, Scharfmann R, Sheppard A, Skinner M, Szyf M, Waterland RA, Waxman DJ, Whitelaw E, Ong K, 450 
Albertsson-Wikland K (2011) Child health, developmental plasticity, and epigenetic programming. Endocr Rev 451 
32 (2):159-224. doi:10.1210/er.2009-0039 452 
5. Fleming TP, Eckert JJ, Denisenko O (2017) The Role of Maternal Nutrition During the Periconceptional 453 
Period and Its Effect on Offspring Phenotype. Adv Exp Med Biol 1014:87-105. doi:10.1007/978-3-319-62414-454 
3_5 455 
6. Williams L, Seki Y, Vuguin PM, Charron MJ (2014) Animal models of in utero exposure to a high fat diet: a 456 
review. Biochim Biophys Acta 1842 (3):507-519. doi:10.1016/j.bbadis.2013.07.006 457 
7. Speakman J, Hambly C, Mitchell S, Krol E (2008) The contribution of animal models to the study of obesity. 458 
Lab Anim 42 (4):413-432. doi:10.1258/la.2007.006067 459 
8. Hughes AN, Oxford JT (2014) A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver 460 
disease: a potential sequence of events. Hepat Med 6:15-23. doi:10.2147/HMER.S57500 461 
9. Sacconnay L, Carrupt PA, Nurisso A (2016) Human sirtuins: Structures and flexibility. J Struct Biol 196 462 
(3):534-542. doi:10.1016/j.jsb.2016.10.008 463 
10. Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, Zang M, Wu SY, Chiang CM, Veenstra TD, Kemper JK 464 
(2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol 465 
Chem 285 (44):33959-33970. doi:10.1074/jbc.M110.122978 466 
11. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F (2004) SREBP transcription factors: master regulators 467 
of lipid homeostasis. Biochimie 86 (11):839-848. doi:10.1016/j.biochi.2004.09.018 468 
12. Suter MA, Chen A, Burdine MS, Choudhury M, Harris RA, Lane RH, Friedman JE, Grove KL, Tackett AJ, 469 
Aagaard KM (2012) A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in 470 
nonhuman primates. FASEB J 26 (12):5106-5114. doi:10.1096/fj.12-212878 471 
13. McCurdy CE, Bishop JM, Williams SM, Grayson BE, Smith MS, Friedman JE, Grove KL (2009) Maternal 472 
high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 119 (2):323-335. 473 
doi:10.1172/JCI32661 474 
14. Bruce KD, Cagampang FR, Argenton M, Zhang J, Ethirajan PL, Burdge GC, Bateman AC, Clough GF, 475 
Poston L, Hanson MA, McConnell JM, Byrne CD (2009) Maternal high-fat feeding primes steatohepatitis in 476 
adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology 477 
50 (6):1796-1808. doi:10.1002/hep.23205 478 
15. Rolo AP, Teodoro JS, Palmeira CM (2012) Role of oxidative stress in the pathogenesis of nonalcoholic 479 
steatohepatitis. Free Radic Biol Med 52 (1):59-69. doi:10.1016/j.freeradbiomed.2011.10.003 480 
16. Nedergaard J, Cannon B (2003) The 'novel' 'uncoupling' proteins UCP2 and UCP3: what do they really do? 481 
Pros and cons for suggested functions. Exp Physiol 88 (1):65-84 482 
17. Baffy G (2005) Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci 10:2082-2096 483 
18. Pan MH, Lai CS, Tsai ML, Ho CT (2014) Chemoprevention of nonalcoholic fatty liver disease by dietary 484 
natural compounds. Mol Nutr Food Res 58 (1):147-171. doi:10.1002/mnfr.201300522 485 
19. Tanaka M, Kita T, Yamasaki S, Kawahara T, Ueno Y, Yamada M, Mukai Y, Sato S, Kurasaki M, Saito T 486 
(2017) Maternal resveratrol intake during lactation attenuates hepatic triglyceride and fatty acid synthesis in 487 
adult male rat offspring. Biochem Biophys Rep 9:173-179. doi:10.1016/j.bbrep.2016.12.011 488 
20. Tiao MM, Lin YJ, Yu HR, Sheen JM, Lin IC, Lai YJ, Tain YL, Huang LT, Tsai CC (2018) Resveratrol 489 
ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-490 
angiotensin system. Lipids Health Dis 17 (1):178. doi:10.1186/s12944-018-0824-3 491 
21. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I (2010) Regulation of SIRT1 in cellular 492 
functions: role of polyphenols. Arch Biochem Biophys 501 (1):79-90. doi:10.1016/j.abb.2010.05.003 493 
22. Schauss AG, Wu X, Prior RL, Ou B, Patel D, Huang D, Kababick JP (2006) Phytochemical and nutrient 494 
composition of the freeze-dried amazonian palm berry, Euterpe oleraceae mart. (acai). J Agric Food Chem 54 495 
(22):8598-8603. doi:10.1021/jf060976g 496 
23. Guerra JFC, Maciel PS, Abreu ICME, Pereira RR, Silva M, Cardoso LM, Pinheiro-Sant’Ana HM, Lima 497 
WG, Silva ME, Pedrosa ML (2015) Dietary açai attenuates hepatic steatosis via adiponectin-mediated effects on 498 
lipid metabolism in high-fat diet mice. J Funct Foods 14:192-202. doi:10.1016/j.jff.2015.01.025 499 
16 
 
24. Pereira RR, de Abreu IC, Guerra JF, Lage NN, Lopes JM, Silva M, de Lima WG, Silva ME, Pedrosa ML 500 
(2016) Acai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with 501 
Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats. Oxid Med Cell Longev 2016:8379105. 502 
doi:10.1155/2016/8379105 503 
25. George S, Brat P, Alter P, Amiot MJ (2005) Rapid determination of polyphenols and vitamin C in plant-504 
derived products. J Agric Food Chem 53 (5):1370-1373. doi:10.1021/jf048396b 505 
26. Giusti MM, Wrolstad RE (2001) Characterization and Measurement of Anthocyanins by UV-Visible 506 
Spectroscopy.  00 (1):F1.2.1-F1.2.13. doi:doi:10.1002/0471142913.faf0102s00 507 
27. Reeves PG, Nielsen FH, Fahey GC, Jr. (1993) AIN-93 purified diets for laboratory rodents: final report of 508 
the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J 509 
Nutr 123 (11):1939-1951. doi:10.1093/jn/123.11.1939 510 
28. Burgueno AL, Cabrerizo R, Gonzales Mansilla N, Sookoian S, Pirola CJ (2013) Maternal high-fat intake 511 
during pregnancy programs metabolic-syndrome-related phenotypes through liver mitochondrial DNA copy 512 
number and transcriptional activity of liver PPARGC1A. J Nutr Biochem 24 (1):6-13. 513 
doi:10.1016/j.jnutbio.2011.12.008 514 
29. Guerra JF, Magalhaes CL, Costa DC, Silva ME, Pedrosa ML (2011) Dietary acai modulates ROS 515 
production by neutrophils and gene expression of liver antioxidant enzymes in rats. J Clin Biochem Nutr 49 516 
(3):188-194. doi:10.3164/jcbn.11-02 517 
30. Padilha PC, Rocha HF, Alves N, Peres WAF (2010) Prevalence of nonalcoholic fatty liver disease in obese 518 
children and adolescents: a systematic review. Rev Paul Pediatr 28 (4):387-393. doi:10.1590/S0103-519 
05822010000400016  520 
31. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total 521 
lipides from animal tissues. J Biol Chem 226 (1):497-509 522 
32. Brunt EM (2016) Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation. Int 523 
J Mol Sci 17 (1). doi:10.3390/ijms17010097 524 
33. Godfrey KM, Reynolds RM, Prescott SL, Nyirenda M, Jaddoe VW, Eriksson JG, Broekman BF (2017) 525 
Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol 5 (1):53-64. 526 
doi:10.1016/S2213-8587(16)30107-3 527 
34. Desai M, Jellyman JK, Han G, Beall M, Lane RH, Ross MG (2014) Maternal obesity and high-fat diet 528 
program offspring metabolic syndrome. Am J Obstet Gynecol 211 (3):237 e231-237 e213. 529 
doi:10.1016/j.ajog.2014.03.025 530 
35. Renault KM, Carlsen EM, Norgaard K, Nilas L, Pryds O, Secher NJ, Cortes D, Jensen JE, Olsen SF, 531 
Halldorsson TI (2015) Intake of carbohydrates during pregnancy in obese women is associated with fat mass in 532 
the newborn offspring. Am J Clin Nutr 102 (6):1475-1481. doi:10.3945/ajcn.115.110551 533 
36. Hachul ACL, Boldarine VT, Neto NIP, Moreno MF, Ribeiro EB, CM OdN, Oyama LM (2018) Maternal 534 
consumption of green tea extract during pregnancy and lactation alters offspring's metabolism in rats. PLoS One 535 
13 (7):e0199969. doi:10.1371/journal.pone.0199969 536 
37. Lima NDS, Caria C, Gambero A, Ribeiro ML (2018) The effect of Guarana (Paullinia cupana) on metabolic 537 
and inflammatory parameters in adult male mice programmed by maternal obesity. Eur J Nutr. 538 
doi:10.1007/s00394-018-1686-1 539 
38. Argentato PP, Morais CA, Santamarina AB, César HC, Estadella D, Rosso VV, Pisani LP (2017) Jussara 540 
(Euterpe edulis Mart.) supplementation during pregnancy and lactation modulates UCP-1 and inflammation 541 
biomarkers induced by trans-fatty acids in the brown adipose tissue of offspring. Clin Nutr Exp 12:50-65. 542 
doi:10.1016/j.yclnex.2016.12.002 543 
39. Mennitti LV, Oyama LM, Santamarina AB, Nascimento OD, Pisani LP (2018) Influence of maternal 544 
consumption of different types of fatty acids during pregnancy and lactation on lipid and glucose metabolism of 545 
the 21-day-old male offspring in rats. Prostaglandins Leukot Essent Fatty Acids 135:54-62. 546 
doi:10.1016/j.plefa.2018.07.001 547 
40. Kemper JK, Choi SE, Kim DH (2013) Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism. 548 
Vitam Horm 91:385-404. doi:10.1016/B978-0-12-407766-9.00016-X 549 
41. Deng XQ, Chen LL, Li NX (2007) The expression of SIRT1 in nonalcoholic fatty liver disease induced by 550 
high-fat diet in rats. Liver Int 27 (5):708-715. doi:10.1111/j.1478-3231.2007.01497.x 551 
42. Nguyen LT, Chen H, Pollock CA, Saad S (2016) Sirtuins-mediators of maternal obesity-induced 552 
complications in offspring? FASEB J 30 (4):1383-1390. doi:10.1096/fj.15-280743 553 
43. Borengasser SJ, Kang P, Faske J, Gomez-Acevedo H, Blackburn ML, Badger TM, Shankar K (2014) High 554 
fat diet and in utero exposure to maternal obesity disrupts circadian rhythm and leads to metabolic programming 555 
of liver in rat offspring. PLoS One 9 (1):e84209. doi:10.1371/journal.pone.0084209 556 
17 
 
44. Alberdi G, Rodriguez VM, Macarulla MT, Miranda J, Churruca I, Portillo MP (2013) Hepatic lipid 557 
metabolic pathways modified by resveratrol in rats fed an obesogenic diet. Nutrition 29 (3):562-567. 558 
doi:10.1016/j.nut.2012.09.011 559 
45. Jump DB, Tripathy S, Depner CM (2013) Fatty acid-regulated transcription factors in the liver. Annu Rev 560 
Nutr 33:249-269. doi:10.1146/annurev-nutr-071812-161139 561 
46. Heyman L, Axling U, Blanco N, Sterner O, Holm C, Berger K (2014) Evaluation of Beneficial Metabolic 562 
Effects of Berries in High-Fat Fed C57BL/6J Mice J Nutr Metab 2014:12. doi:10.1155/2014/403041 563 
47. Heyman-Linden L, Seki Y, Storm P, Jones HA, Charron MJ, Berger K, Holm C (2016) Berry intake 564 
changes hepatic gene expression and DNA methylation patterns associated with high-fat diet. J Nutr Biochem 565 
27:79-95. doi:10.1016/j.jnutbio.2015.08.022 566 
48. de Souza MO, Souza ESL, de Brito Magalhaes CL, de Figueiredo BB, Costa DC, Silva ME, Pedrosa ML 567 
(2012) The hypocholesterolemic activity of acai (Euterpe oleracea Mart.) is mediated by the enhanced 568 
expression of the ATP-binding cassette, subfamily G transporters 5 and 8 and low-density lipoprotein receptor 569 
genes in the rat. Nutr Res 32 (12):976-984. doi:10.1016/j.nutres.2012.10.001 570 
49. Karavia EA, Papachristou DJ, Liopeta K, Triantaphyllidou IE, Dimitrakopoulos O, Kypreos KE (2012) 571 
Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice. 572 
Mol Med 18:901-912. doi:10.2119/molmed.2012.00113 573 
50. Garcia-Heredia A, Kensicki E, Mohney RP, Rull A, Triguero I, Marsillach J, Tormos C, Mackness B, 574 
Mackness M, Shih DM, Pedro-Botet J, Joven J, Saez G, Camps J (2013) Paraoxonase-1 deficiency is associated 575 
with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approach. J Proteome Res 576 
12 (4):1946-1955. doi:10.1021/pr400050u 577 
51. Fukushima M, Nakano M, Morii Y, Ohashi T, Fujiwara Y, Sonoyama K (2000) Hepatic LDL receptor 578 
mRNA in rats is increased by dietary mushroom (Agaricus bisporus) fiber and sugar beet fiber. J Nutr 130 579 
(9):2151-2156. doi:10.1093/jn/130.9.2151 580 
52. Cortez-Pinto H, Machado MV (2009) Uncoupling proteins and non-alcoholic fatty liver disease. J Hepatol 581 
50 (5):857-860. doi:10.1016/j.jhep.2009.02.019 582 
53. Chen YT, Lin YC, Lin JS, Yang NS, Chen MJ (2018) Sugary Kefir Strain Lactobacillus mali APS1 583 
Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats. Mol Nutr Food Res 584 
62 (8):e1700903. doi:10.1002/mnfr.201700903 585 
54. Bayele HK, Debnam ES, Srai KS (2016) Nrf2 transcriptional derepression from Keap1 by dietary 586 
polyphenols. Biochem Biophys Res Commun 469 (3):521-528. doi:10.1016/j.bbrc.2015.11.103 587 
55. Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its 588 
activation by oxidative stress. J Biol Chem 284 (20):13291-13295. doi:10.1074/jbc.R900010200 589 
56. Anderson JW, Baird P, Davis RH, Jr., Ferreri S, Knudtson M, Koraym A, Waters V, Williams CL (2009) 590 
Health benefits of dietary fiber. Nutr Rev 67 (4):188-205. doi:10.1111/j.1753-4887.2009.00189.x 591 
57. Garcia-Diez F, Garcia-Mediavilla V, Bayon JE, Gonzalez-Gallego J (1996) Pectin feeding influences fecal 592 
bile acid excretion, hepatic bile acid and cholesterol synthesis and serum cholesterol in rats. J Nutr 126 593 
(7):1766-1771. doi:10.1093/jn/126.7.1766 594 
58. Caz V, Gil-Ramirez A, Largo C, Tabernero M, Santamaria M, Martin-Hernandez R, Marin FR, Reglero G, 595 
Soler-Rivas C (2015) Modulation of Cholesterol-Related Gene Expression by Dietary Fiber Fractions from 596 
Edible Mushrooms. J Agric Food Chem 63 (33):7371-7380. doi:10.1021/acs.jafc.5b02942 597 
59. Simino LAP, de Fante T, Fontana MF, Borges FO, Torsoni MA, Milanski M, Velloso LA, Torsoni AS 598 
(2017) Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and 599 
promote metabolic impairment after new challenge to high-fat diet. Nutr Metab (Lond) 14:16. 600 
doi:10.1186/s12986-017-0168-4 601 
60. Pirola CJ, Gianotti TF, Burgueno AL, Rey-Funes M, Loidl CF, Mallardi P, Martino JS, Castano GO, 602 
Sookoian S (2013) Epigenetic modification of liver mitochondrial DNA is associated with histological severity 603 
of nonalcoholic fatty liver disease. Gut 62 (9):1356-1363. doi:10.1136/gutjnl-2012-302962 604 
61. Baselga-Escudero L, Pascual-Serrano A, Ribas-Latre A, Casanova E, Salvado MJ, Arola L, Arola-Arnal A, 605 
Blade C (2015) Long-term supplementation with a low dose of proanthocyanidins normalized liver miR-33a and 606 
miR-122 levels in high-fat diet-induced obese rats. Nutr Res 35 (4):337-345. doi:10.1016/j.nutres.2015.02.008607 
18 
 
Table 1: Sequence of oligonucleotides 608 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
Sirt1 CTGTTTCCTGTGGGATACCTGACT ATCGAACATGGCTTGAGGATCT 
Srebf1 CCCAGGGCAGCTCTGTACTCC AAGCTGTCCCGCAGGTA 
Fasn CTTGGGTGCCGATTACAACC GCCCTCCCGTACACTCACTC 
Ucp2 GGTAAAGGTCCGCTTCCAGG GCAAGGGAGGTCGTCTGTCA 
β2-microglobulin TGACCGTATCTTTCTGGTG ATTTGAGGTGGGTGGAACTG 
Sirt1: sirtuin 1; Srebf1: sterol regulatory element-binding protein 1; Fasn: fatty acid synthase; Ucp2: uncoupling 609 
protein 2 610 
611 
19 
 
Table 2: Body and liver weight, serum lipid profile, liver function, liver lipid content, food intake, and food 612 
intake of dams 613 
 C HF CA HFA 
Initial body weight (g) 210.1 ± 8.83 210.4 ± 10.48 205.4 ± 8.35 218.9 ± 12.84 
Pre-Gestational body 
weight (g) 
215.4 ± 11.16 220.7 ± 13.62 212.1 ± 8.49 226.5 ± 15.06 
Final body weight (g) 213.1 ± 20.78 230.9 ± 12.61 237.7 ± 27.63 255.6 ± 29.68# 
Liver weight (g) 7 ± 1.17 10.23 ± 2.89#* 5.90 ± 0.52 8.39 ± 0.99* 
Relative liver weight 3.33 ± 0.73 4.45 ± 1.03#* 2.53 ±0.55 3.30 ± 0.34§ 
Total cholesterol (mmol/l) 2.96 ± 0.74 3.6 ± 1.69 2.23 ± 0.68 5.52 ± 1.66#*§ 
Triglyceride (mmol/l) 1.14 ± 0.49 0.93 ± 0.38 0.66 ± 0.17 0.83 ± 0.19 
AST (U/l) 15.23 ± 4.81 22.63 ± 3.1# 20.69 ± 3.72 23.11 ± 3.68# 
ALT (U/l) 23.13 ± 7.4 62.11 ± 20.88#* 24.61 ± 7.54 60.54 ± 14.2#* 
Liver fat (mg/g) 98.62 ± 37.46 214.9 ± 71.8#* 56.79 ± 18.16 117.5 ± 45.62§ 
Liver cholesterol  (mg/g) 3.75 ± 0.4 28.3 ± 4.16#* 3.36 ± 0.33 17.21 ± 6.67#*§ 
Liver triglyceride  (mg/g) 19.45 ± 13.36 31.39 ± 4.51* 18.08 ± 2.67 22.37 ± 7.84 
Food intake (g/d) 13.82 ± 1.36 9.66 ± 1.15#* 14.73 ± 1.14 10.91 ± 0.67#* 
Caloric intake (kj/d) 229.82 ± 22.59 217.85 ± 26.08 240.03 ± 18.06 242.38 ± 14.95 
p < 0.05: # versus C, *versus CA and §versus HF 614 
C: control diet; HF: high-fat diet; CA: açaí diet; HFA: high-fat açaí diet. The results are shown as the mean ± 615 
SD (n=7 dams per group). One-way ANOVA followed by a Tukey post hoc test.  616 
617 
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Table 3: Body and liver weight of offspring P1 and P21. 618 
 Pups-P1 Pups-P21 
 HF HFA C HF CA HFA 
Body weight (g) 5.43 ± 1.07 5.93 ± 0.59 30.49 ± 3 33.67 ± 5.8* 23.96 ± 4.43 38.36 ± 7.46*# 
Liver weight (g) 0.296 ± 0.02 0.217 ± 0.06§ 1.11 ± 0.14 1.64 ± 0.26#* 1.03 ± 0.21 1.56 ± 0.23#* 
Relative liver weight 5.65 ± 1.14 3.75 ± 1.28§ 3.67 ± 0.54 4.96 ± 0.89# 4.32 ± 0.38 4.1 ± 0.25§ 
p < 0.05: # versus C, *versus CA and §versus HF 619 
C: control diet; HF: high-fat diet; CA: açaí diet; HFA: high-fat açaí diet. Litter size six per dam. The results are 620 
shown as the mean ± SD (n=7 pups per group). One-way ANOVA followed by a Tukey post hoc test.  621 
622 
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Table 4: Body and liver weight, serum lipid profile, liver function and liver lipid content of P21. 623 
 C HF CA HFA 
Total cholesterol (mmol/l) 4.22 ± 0.51 6.7 ± 1.88#* 4.52 ± 0.77 3.87 ± 0.41§ 
Triglyceride (mmol/l) 1.2 ± 0.86 0.96 ± 0.66 1.24 ± 0.84 1.24 ± 0.28 
AST (U/l) 96.34 ± 10.17 103 ± 17.11 98.22 ± 7.21 94.11 ± 10.43 
ALT (U/l) 29.11 ± 5.63 32.26 ± 14.96 23.17 ± 4.36 37.43 ± 9.26 
Liver fat (mg/g) 63.89 ± 37.69 88.39 ± 28.63 71.48 ± 7.28 81.89 ± 18.94 
Liver cholesterol (mg/g) 4.82 ± 1.35 11.79 ± 3.58#* 5.04 ± 0.45 11.28 ± 2.05#* 
Liver triglyceride (mg/g) 22 ± 7.26 26.42 ± 6.40* 14.13 ± 4.84 26.88 ± 7.76* 
p < 0.05: # versus C, *versus CA and §versus HF 624 
C: control diet; HF: high-fat diet; CA: açaí diet; HFA: high-fat açaí diet; AST: aspartate aminotransferase; ALT: 625 
alanine aminotransferase. The results are shown as the mean ± SD (n=7 pups per group). One-way ANOVA 626 
followed by a Tukey post hoc test. 627 
628 
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Legends of figures 629 
Fig. 1: a- Representative histological sections of the liver of dams fed with a control diet (C), high-fat diet (HF), 630 
açaí diet (CA) and high-fat supplemented with açaí (HFA), stained with hematoxylin and eosin. Black arrow 631 
shows macrosteatosis and red arrow shows microsteatosis. The images were photographed at a magnification of 632 
400 ×. Bar Scale = 50 μm; b- Grade of hepatic steatosis of dams (n= 7 dams per group). Value of p <0.05 was 633 
considered statistically significant for the Kruskal-Wallis. ** < 0.01, *** < 0.005 634 
Fig. 2: mRNA abundance for genes related to lipid metabolism in the liver of dams relative to beta-2-635 
microglobulin. HF: high-fat diet; HFA: high-fat açaí diet; Sirt1: sirtuin 1; Srebf1: sterol regulatory element 636 
binding transcription factor 1; Fasn: fatty acid synthase; Ucp2: uncoupling protein 2. The results are shown as 637 
the mean ± SD (n=7 dams per group). Analyses by Student’s t-test. * p < 0.05; ** p < 0.01 638 
Fig. 3:  Western blotting for SIRT1 (a) and SREBP1 (b) of dams. Graphs represent data from Western blotting 639 
quantification. HF: high-fat diet and HFA: high-fat supplemented with açaí. Data are shown as median and 640 
range (minimum and maximum value), (n= 7 dams per group). Value of p <0.05 was considered statistically 641 
significant for the Kruskal-Wallis 642 
Fig. 4: a- Representative histological sections of the liver of offspring P21 fed with a control diet (C), high-fat 643 
diet (HF), açaí diet (CA) and high-fat supplemented with açaí (HFA), stained with hematoxylin and eosin. Black 644 
arrow shows macrosteatosis and red arrow shows microsteatosis. The images were photographed at a 645 
magnification of 400 ×. Bar Scale = 50 μm; b- Grade of hepatic steatosis of dams (n= 7 pups per group). Value 646 
of p <0.05 was considered statistically significant for the Kruskal-Wallis. * < 0.05, *** < 0.005 647 
Fig. 5:  mRNA abundance for genes related to lipid metabolism in the liver of offspring P1 (a) and offspring 648 
P21 (b) relative to beta-2-microglobulin. HF: high-fat diet; HFA: high-fat açaí diet; Sirt1: sirtuin 1; Srebf1: 649 
sterol regulatory element binding transcription factor; Fasn: fatty acid synthase; Ucp2: uncoupling protein 2. 650 
The results are shown as the mean ± SD (n=7 pups per group). Analyses by Student’s t-test. * p < 0.05; *** p < 651 
0.005 652 
Fig. 6: Western blotting for SIRT1 and SREBP1 of offspring P1 (a and b) and offspring P21 (c and d). Graphs 653 
represent data from Western blotting quantification. HF: high-fat diet and HFA: high-fat supplemented with 654 
açaí. The data are shown as median and range (minimum and maximum values), (n= 7 pups per group). Value 655 
of p <0.05 was considered statistically significant for the Kruskal-Wallis 656 
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